Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present InMed Pharmaceuticals, Inc. (OTC: IMLFF).

Full DD Report for IMLFF

You must become a subscriber to view this report.


Recent News from (OTC: IMLFF)

5 of Today's Biggest Marijuana Stock Losers - Tuesday, May 15th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Tuesday, May 15th including Namaste Technologies Inc. (TSXV:N) (OTC:NXTTF) and more... Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF) Shares of Abattis Bioceuticals Corp. dropped 5.35...
Source: Daily Marijuana Observer
Date: May, 15 2018 17:12
Weekly Cannabis Report: Aurora/MedReleaf, Canopy, Maricann
Welcome to our Weekly Cannabis Report, a reliable source for cannabis investors to receive the latest developments and analysis. Weekly Note to Readers The cannabis sector saw its biggest acquisition to-date when Aurora (ACBFF) finally announced the acquisition of MedReleaf (MEDFF) for a h...
Source: SeekingAlpha
Date: May, 15 2018 10:20
InMed Files Patent Application for INM-085 Glaucoma Program
InMed Files Patent Application for INM-085 Glaucoma Program Canada NewsWire VANCOUVER, May 14, 2018 VANCOUVER , May 14, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical comp...
Source: Canada Newswire
Date: May, 14 2018 07:25
5 of Today's Biggest Marijuana Stock Losers - Friday, May 11th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Friday, May 11th including Terra Tech Corp. (OTC:TRTC) and more... Alternate Health Corp. (CSE:AHG) (OTC:AHGIF) Shares of Alternate Health Corp. dropped 5.79% today on lower than average...
Source: Daily Marijuana Observer
Date: May, 11 2018 17:47
InMed Reports Third Quarter Fiscal 2018 Financial Results and Provides Business Update
InMed Reports Third Quarter Fiscal 2018 Financial Results and Provides Business Update Canada NewsWire VANCOUVER, May 11, 2018 VANCOUVER , May 11, 2018 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-b...
Source: Canada Newswire
Date: May, 11 2018 07:25
5 of Today's Biggest Marijuana Stock Losers - Thursday, May 10th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Thursday, May 10th including CV Sciences, Inc. (OTC:CVSI) and more... CV Sciences, Inc. (OTC:CVSI) Shares of CV Sciences, Inc. dropped 5.34% today on lower than average trading volume on...
Source: Daily Marijuana Observer
Date: May, 10 2018 17:10
5 of Today's Biggest Marijuana Stock Gainers - Wednesday, May 9th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Wednesday, May 9th including MYM Neutraceuticals Inc. (CSE:MYM) (OTC:MYMMF) and more... InMed Pharmaceuticals, Inc. (TSXV:IN) (OTC:IMLFF) Shares of InMed Pharmaceuticals, Inc. rose 34.97%...
Source: Daily Marijuana Observer
Date: May, 09 2018 17:44
Weekly Cannabis Report: MedReleaf Sell, TGOD IPO, Loblaw Wins
Welcome to our Weekly Cannabis Report, a reliable source for cannabis investors to receive the latest developments and analysis. Weekly Note to Readers There are three things that cannabis investors need to know from last week. Fourth-largest Canadian cannabis company MedReleaf is reported...
Source: SeekingAlpha
Date: May, 08 2018 15:20
OTC Markets Group Welcomes InMed Pharmaceuticals Inc. to OTCQX
NEW YORK , May 4, 2018 /PRNewswire/ --  OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced InMed Pharmaceuticals Inc. (TSX: IN; OTCQX: IMLFF), a cannabinoid-focused biopharmaceutical company, has qualified to ...
Source: PR Newswire
Date: May, 04 2018 08:30
Weekly Cannabis Report: U.S. Federal Legalization And The Green Organic Dutchman's IPO
Welcome to our Weekly Cannabis Report, a reliable source for cannabis investors to receive the latest developments and analysis. Weekly Note to Readers This past week was relatively quiet for the cannabis world and we are seeing some weakness across the sector as share prices drifted lower...
Source: SeekingAlpha
Date: May, 01 2018 17:10

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-150.5340.527960.548420.51288,819
2018-08-140.5650.532870.565330.501764,441
2018-08-130.5970.56090.5980.532139741,399
2018-08-100.6130.5950.613770.595175,179
2018-08-090.61070.61080.6280.6042261,817

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-14124,248764,44116.2534Cover
2018-08-13116,016589,39919.6838Cover
2018-08-1066,039175,17937.6980Short
2018-08-09128,357261,81749.0255Short
2018-08-08118,532304,55838.9194Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on IMLFF.


About InMed Pharmaceuticals, Inc. (OTC: IMLFF)

Logo for InMed Pharmaceuticals, Inc. (OTC: IMLFF)

lt p gt InMed Pharmaceuticals Inc. is a pre clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid based therapies to treat human diseases with high unmet medical needs. The Company has three core assets: a proprietary Bioinformatics assessment tool to match individual or combination of cannabinoids against disease targets a proprietary Biosynthesis cannabinoid manufacturing system to economically produce all cannabinoids at pharmaceutical grade gt . purity and drug development program enabled by the two aforementioned tools. Leaders in the pipeline include a treatment for the symptoms and, potentially, the underlying disease in Epidermolysis Bullosa, a rare, devastating genetic skin disorder and, a once a day eyedrops formulation of cannabinoids to treat Glaucoma, one of the leading causes of blindness in the developed world.

 

Contact Information

 

 

Current Management

  • Eric A. Adams / CEO
  • Jeff Charpentier / CFO
  • Sazzad Hossain / Chief Scientific Officer
  • Martin Bott / Independent Director, Audit Committee Member
  • Adam Cutler / Independent Director, Audit Committee Member
  • William Garner / Independent Director, Compensation Committee Member
  • Andrew Hull / Independent Director, Compensation Committee Member

Current Share Structure

  • Market Cap: $190,238,229 - 03/09/2018
  • Issue and Outstanding: 152,190,583 - 02/13/2018

 


Recent Filings from (OTC: IMLFF)

OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: March, 01 2018
Supplemental Information - Certification of Interim Filings - CEO
Filing Type: Supplemental Information - Certification of Interim Filings - CEOFiling Source: OTC Markets
Filing Date: February, 22 2018
Supplemental Information - Certificacion of interim filings - CFO
Filing Type: Supplemental Information - Certificacion of interim filings - CFOFiling Source: OTC Markets
Filing Date: February, 22 2018
Management Discussion and Analysis - Managements Discussion and Analysis
Filing Type: Management Discussion and Analysis - Managements Discussion and AnalysisFiling Source: OTC Markets
Filing Date: February, 22 2018
Quarterly Report - Financial Statements December 31 2017
Filing Type: Quarterly Report - Financial Statements December 31 2017Filing Source: OTC Markets
Filing Date: February, 22 2018
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: February, 13 2018
Supplemental Information - Report of exempt distribution excluding Schedule 1 of 45-106F1
Filing Type: Supplemental Information - Report of exempt distribution excluding Schedule 1 of 45-106F1Filing Source: OTC Markets
Filing Date: January, 10 2018
Supplemental Information - Material Change Report
Filing Type: Supplemental Information - Material Change ReportFiling Source: OTC Markets
Filing Date: January, 08 2018
Supplemental Information - Certification of Interim Filings - CEO
Filing Type: Supplemental Information - Certification of Interim Filings - CEOFiling Source: OTC Markets
Filing Date: November, 21 2017
Supplemental Information - Certification of Interim Filings - CFO
Filing Type: Supplemental Information - Certification of Interim Filings - CFOFiling Source: OTC Markets
Filing Date: November, 21 2017

 

 


Daily Technical Chart for (OTC: IMLFF)

Daily Technical Chart for (OTC: IMLFF)


Stay tuned for daily updates and more on (OTC: IMLFF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: IMLFF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in IMLFF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of IMLFF and does not buy, sell, or trade any shares of IMLFF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/